How often have you wondered “what do I need to do” when you’ve been faced with the prospect of running a non-interventional study? Especially, if you are more familiar and comfortable with running clinical trials.
This is where I think we are missing a trick when we train team members in the requirements of ICH GCP. Most GCP training skims over the foundational aspects…the ‘why’ we need to do the training (= prevent a reoccurrence of the Nazi doctor experiments)….why the Nuremberg Code and the Declaration of Helsinki were needed (= before they were created no international law or informal statement existed that differentiated between legal and illegal human experimentation).
The Declaration of Helsinki [ref 1] defines the “ethical principles for medical research involving human subjects”. This Declaration is the ethical foundation for:
- Clinical trials of drugs
- Non-interventional studies of drugs
- Observational studies (no drugs)
- Clinical trials and observational studies of medical devices
The Declaration of Helsinki forms the basis for ICH GCP (drugs) and ISO 14155 (GCP for medical devices)…and is the framework for non-interventional study regulations…globally.
Once you understand this, you will see the global similarities in the requirements for running non-interventional studies, which include:
- Study participation must be voluntary
- Voluntary informed consent is essential
- Every precaution must be taken to protect the privacy of research subjects and the confidentiality of their personal information.
- Researchers must have appropriate education, training, and qualifications
- Design and performance must be clearly described and justified in a protocol
- Protocol should contain a statement of the ethical considerations involved and should indicate how the principles in this Declaration have been addressed
- Protocol must be submitted for approval to a research ethics committee before the study begins
- The research study must be registered in a publicly accessible database before recruitment of the first subject.
- No amendment to the protocol may be made without approval by the research ethics committee.
- At the end of the study, researchers must submit a final report to the research ethics committee containing a summary of the study’s findings and conclusions.
- Researchers have a duty to make publicly available the results of their research are accountable for the completeness and accuracy of their reports.
References:
- World Medical Association (WMA) – Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects (October 2013): https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
Share this story...
Lithuania – Leaping into Digital Health Future with RWE and RWD Innovations
RWE 201 - Lithuania – Leaping into Digital Health Future with RWE and RWD Innovations EU Partnership Agreement: https://ec.europa.eu/commission/presscorner/detail/en/ip_22_2547Lithuania is actively implementing Real-World Evidence (RWE) and Real-World Data (RWD) [...]
RWE Guest Post – Does Real-World Evidence Play a Role in G-BA’s Benefit Assessments in Germany?
RWE 201 - RWE Guest Post - Does real-world evidence play a role in G-BA's benefit assessments in Germany? Guest: Anja PownellGerman Market Access – Simplified: https://germanmarketaccesssimplified.com/IntroductionThe German [...]
RWE Guest Post – Germany – From Concept to Evaluation: The Journey of RWE requests by the G-BA
RWE 201 - RWE Guest Post – Germany - From Concept to Evaluation: The Journey of RWE requests by the G-BA Guest: Anja PownellGerman Market Access – Simplified: [...]
Spain – Championing the Ethical and Responsible Use of Real World Data
RWE 201 - Spain – Championing the Ethical and Responsible Use of Real World Data Farmindustria Code of Conduct: https://codigoprotecciondatos.farmaindustria.org/sites/medicamentosinnovadores/docs/PRODF484450.pdfIn 2022, the Spanish Data Protection Agency (AEPD) gave its [...]
EU – RWD/RWE is Embedded into the New EU Medicines Regulations
RWE 201 - EU – RWD/RWE is Embedded into the New EU Medicines Regulations Coming Soon…New EU Medicines Regulations: https://health.ec.europa.eu/medicinal-products/pharmaceutical-strategy-europe/reform-eu-pharmaceutical-legislation_enIn 2023, the European Commission undertook an ambitious overhaul of [...]
EU – EU’s Action Plan for Real-World Data (RWD) & RWE
RWE 201 - EU – EU's Action Plan for Real-World Data (RWD) & RWE The European Union has embarked on an ambitious journey to weave Real World Evidence (RWE) [...]







